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Abstract   
 
Background 
Previously, we have demonstrated the cardioprotective effect of interleukin-11 in animal 
models of acute coronary syndrome.  In this study, we sought to evaluate its cardioprotective 
potential during prolonged hypothermic global ischemia and subsequent reperfusion using a rat 
heart donor model. 
 
Methods 
Interleukin-11 was administered intravenously 10 minutes before harvesting the rat heart.  
The hearts were preserved in cold (4°C) Krebs-Henseleit buffer for 6 hours, and then attached to 
a Langendorff perfusion apparatus and reperfused with an oxygenated Krebs-Henseleit solution 
containing interleukin-11.  Normal saline was used instead of interleukin-11 in the control 
group.  Functional recovery of the reperfused heart was observed by using a left ventricular 
balloon.  Myocardial cell injury was quantified by measuring the biomarkers collected from 
the coronary effluent.  Apoptotic cells were identified and counted using the TUNEL staining 
technique. 
 
Results 
Interleukin -11 administration improved myocardial function after 6 hours of cold ischemia.  
Although there were no significant differences in any of the baseline-measured values between 
the two groups, left ventricular developed pressure (LVDP) and changes in left ventricular 
pressures (dP/dt) were significantly higher in the interleukin-11 group at 120-minute reperfusion.  
The number of TUNEL-labeled cardiomyocytes was also significantly smaller in the 
interleukin-11 group. 
 
Conclusions 
The administration of interleukin-11 showed a significant recovery of cardiac contractile 
function after 6 hours of cold ischemia.  Our data suggest that it may have significant 
therapeutic potential for maintaining the functional viability of the heart exposed to prolonged 
hypothermic global ischemia. 
 
 
 
 
 
